Clinical Trial to Investigate the Influence of Drug Interaction After Oral Administration of Tamsulosin and SK3530 [mirodenafil] in Healthy Male Volunteers

Trial Profile

Clinical Trial to Investigate the Influence of Drug Interaction After Oral Administration of Tamsulosin and SK3530 [mirodenafil] in Healthy Male Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 27 May 2013

At a glance

  • Drugs Mirodenafil (Primary) ; Tamsulosin
  • Indications Benign prostatic hyperplasia; Erectile dysfunction; Urination disorders
  • Focus Pharmacodynamics
  • Sponsors SK Chemicals
  • Most Recent Events

    • 23 Aug 2012 Results published in Clinical Therapeutics.
    • 25 Aug 2011 New source identified and integrated (Korean Clinical Trials Register KCT0000117).
    • 10 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top